Want to see MRMD full AI Analyst Report?
MariMed (MRMD) Ratios
MariMed Ratios
MRMD's free cash flow for Q2 2026 was $1.92M. For the 2026 fiscal year, MRMD's free cash flow was decreased by $-298.00K and operating cash flow was $2.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.00 | 1.10 | 1.67 | 1.67 | 1.64 |
| Quick Ratio | 0.38 | 0.41 | 0.85 | 0.93 | 1.28 |
| Cash Ratio | 0.15 | 0.15 | 0.47 | 0.37 | 1.09 |
| Solvency Ratio | -0.02 | -0.01 | -0.06 | 0.19 | 0.12 |
| Operating Cash Flow Ratio | 0.13 | 0.14 | 0.26 | 0.28 | 1.32 |
| Short-Term Operating Cash Flow Coverage | 3.01 | 0.74 | 10.94 | 1.38 | 25.43 |
| Net Current Asset Value | $ -93.27M | $ -93.60M | $ -74.78M | $ -50.75M | $ -42.29M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.43 | 0.41 | 0.25 | 0.20 |
| Debt-to-Equity Ratio | 1.93 | 1.44 | 1.12 | 0.64 | 0.64 |
| Debt-to-Capital Ratio | 0.66 | 0.59 | 0.53 | 0.39 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.62 | 0.53 | 0.48 | 0.31 | 0.31 |
| Financial Leverage Ratio | 3.91 | 3.36 | 2.74 | 2.59 | 3.25 |
| Debt Service Coverage Ratio | 0.58 | 0.35 | 0.18 | 2.87 | 3.39 |
| Interest Coverage Ratio | -0.28 | 0.42 | 1.64 | 12.03 | 11.40 |
| Debt to Market Cap | 2.55 | 1.81 | 0.66 | 0.26 | 0.07 |
| Interest Debt Per Share | 0.28 | 0.25 | 0.25 | 0.12 | 0.08 |
| Net Debt to EBITDA | 9.66 | 5.87 | 5.87 | 1.07 | -0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.22% | 39.80% | 44.36% | 47.73% | 54.55% |
| EBIT Margin | -1.29% | 1.88% | 1.74% | 15.82% | 21.55% |
| EBITDA Margin | 5.91% | 8.76% | 7.51% | 19.34% | 23.84% |
| Operating Profit Margin | -1.29% | 1.84% | 10.15% | 15.20% | 22.12% |
| Pretax Profit Margin | -6.80% | -2.51% | -4.44% | 14.56% | 19.61% |
| Net Profit Margin | -9.06% | -7.70% | -10.79% | 10.05% | 5.95% |
| Continuous Operations Profit Margin | -9.06% | -7.68% | -10.77% | 10.16% | 6.28% |
| Net Income Per EBT | 133.35% | 306.55% | 243.04% | 69.04% | 30.34% |
| EBT Per EBIT | 525.24% | -136.26% | -43.74% | 95.77% | 88.66% |
| Return on Assets (ROA) | -7.15% | -5.88% | -8.17% | 8.85% | 5.86% |
| Return on Equity (ROE) | -27.92% | -19.74% | -22.40% | 22.90% | 19.08% |
| Return on Capital Employed (ROCE) | -1.44% | 1.84% | 9.12% | 16.20% | 27.99% |
| Return on Invested Capital (ROIC) | -1.38% | 1.70% | 8.92% | 10.73% | 8.73% |
| Return on Tangible Assets | -8.98% | -7.05% | -9.59% | 10.37% | 5.97% |
| Earnings Yield | -42.24% | -27.93% | -16.05% | 11.20% | 2.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 16.01 | 16.89 | 18.61 | 17.80 | 35.00 |
| Payables Turnover | 6.99 | 7.21 | 9.19 | 10.57 | 10.83 |
| Inventory Turnover | 2.79 | 2.84 | 3.27 | 3.60 | 5.65 |
| Fixed Asset Turnover | 1.58 | 1.48 | 1.46 | 1.73 | 1.81 |
| Asset Turnover | 0.79 | 0.76 | 0.76 | 0.88 | 0.99 |
| Working Capital Turnover Ratio | 63.25 | 12.44 | 7.77 | 7.65 | 15.97 |
| Cash Conversion Cycle | 101.61 | 99.52 | 91.60 | 87.46 | 41.30 |
| Days of Sales Outstanding | 22.79 | 21.60 | 19.62 | 20.50 | 10.43 |
| Days of Inventory Outstanding | 131.04 | 128.53 | 111.72 | 101.48 | 64.59 |
| Days of Payables Outstanding | 52.22 | 50.62 | 39.74 | 34.52 | 33.71 |
| Operating Cycle | 153.84 | 150.14 | 131.33 | 121.98 | 75.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 |
| Free Cash Flow Per Share | 0.02 | -0.02 | -0.04 | -0.02 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 5.90 | 0.53 | 0.39 | 0.56 | 1.89 |
| Capital Expenditure Coverage Ratio | 6.59 | 0.54 | 0.39 | 0.57 | 1.93 |
| Operating Cash Flow Coverage Ratio | 0.08 | 0.08 | 0.10 | 0.20 | 1.47 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.04 | 0.05 | 0.05 | 0.30 |
| Free Cash Flow Yield | 19.04% | -13.52% | -12.86% | -4.51% | 6.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.37 | -3.58 | -6.23 | 8.93 | 39.09 |
| Price-to-Sales (P/S) Ratio | 0.21 | 0.28 | 0.67 | 0.90 | 2.32 |
| Price-to-Book (P/B) Ratio | 0.66 | 0.71 | 1.40 | 2.04 | 7.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.25 | -7.40 | -7.77 | -22.15 | 16.33 |
| Price-to-Operating Cash Flow Ratio | 4.46 | 6.42 | 12.62 | 16.45 | 7.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.15 | 0.13 | 0.03 | 0.11 | 0.22 |
| Enterprise Value Multiple | 13.29 | 9.02 | 14.81 | 5.71 | 9.57 |
| Enterprise Value | 125.49M | 124.73M | 165.34M | 147.90M | 277.08M |
| EV to EBITDA | 13.29 | 9.02 | 14.81 | 5.71 | 9.57 |
| EV to Sales | 0.79 | 0.79 | 1.11 | 1.10 | 2.28 |
| EV to Free Cash Flow | 19.22 | -21.19 | -12.87 | -27.24 | 16.03 |
| EV to Operating Cash Flow | 16.31 | 18.38 | 20.90 | 20.23 | 7.73 |
| Tangible Book Value Per Share | 0.02 | 0.07 | 0.11 | 0.10 | 0.10 |
| Shareholders’ Equity Per Share | 0.13 | 0.16 | 0.20 | 0.17 | 0.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.33 | -2.06 | -1.43 | 0.30 | 0.68 |
| Revenue Per Share | 0.41 | 0.42 | 0.41 | 0.40 | 0.37 |
| Net Income Per Share | -0.04 | -0.03 | -0.04 | 0.04 | 0.02 |
| Tax Burden | 1.33 | 3.07 | 2.43 | 0.69 | 0.30 |
| Interest Burden | 5.25 | -1.33 | -2.55 | 0.92 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.38 | 0.30 | 0.26 | 0.30 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.05 | 0.11 |
| Income Quality | -0.53 | -0.56 | -0.49 | 0.54 | 4.70 |
Currency in USD
